1.50

1.96% -0.03

Fortress Biotech Inc (FBIO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché FBIO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.53

Aprire:

$1.5

Volume 24 ore:

246.11K

Relative Volume:

0.84

Capitalizzazione di mercato:

$46.40M

Reddito:

$80.97M

Utile/perdita netta:

$-78.31M

Rapporto P/E:

-0.1353

EPS:

-11.0849

Flusso di cassa netto:

$-129.56M

1 W Prestazione:

-4.46%

1M Prestazione:

-12.28%

6M Prestazione:

-15.73%

1 anno Prestazione:

-14.29%

Intervallo 1D:

$1.46

$1.57

Intervallo di 1 settimana:

$1.45

$1.6366

Portata 52W:

$1.325

$2.89

Fortress Biotech Inc Stock (FBIO) Company Profile

Nome

Fortress Biotech Inc

Settore

Healthcare (1155)

Industria

Biotechnology (677)

Telefono

781-652-4500

Indirizzo

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Dipendente

101

Cinguettio

@fortressbio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

FBIO's Discussions on Twitter

Confronta FBIO con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FBIO Fortress Biotech Inc	1.50	46.40M	80.97M	-78.31M	-129.56M	-11.08
VRTX Vertex Pharmaceuticals Inc	477.52	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	561.49	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	595.70	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	232.75	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	229.22	26.16B	3.81B	-644.79M	-669.77M	-6.24

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-03-15	Ripresa	ROTH MKM	Buy
2022-08-04	Iniziato	Ladenburg Thalmann	Buy
2020-10-02	Iniziato	The Benchmark Company	Buy
2019-12-18	Iniziato	B. Riley FBR	Buy
2018-02-28	Iniziato	B. Riley FBR, Inc.	Buy
2017-07-11	Iniziato	Rodman & Renshaw	Buy
2017-03-22	Iniziato	JMP Securities	Mkt Outperform
2016-10-03	Iniziato	ROTH Capital	Buy

Mostra tutto

Fortress Biotech Inc Borsa (FBIO) Ultime notizie

Apr 16, 2025

Fortress Biotech Board Member Resigns for New Role - TipRanks

Apr 16, 2025

When the Price of (FBIOP) Talks, People Listen - news.stocktradersdaily.com

Apr 16, 2025

Apr 15, 2025

Fortress Biotech (NASDAQ:FBIOP) Trading Down 2.1% – What’s Next? - Defense World

Apr 15, 2025

Apr 09, 2025

This Fortress Biotech Insider Increased Their Holding By 26% Last Year - Yahoo Finance

Apr 09, 2025

Apr 07, 2025

Roth Capital Forecasts Reduced Earnings for Fortress Biotech - Defense World

Apr 07, 2025

Apr 04, 2025

FBIO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Tuesday Deadline in Securities Class ActionFBIO - MarketScreener

Apr 04, 2025

Apr 01, 2025

SEC Form POS AM filed by Fortress Biotech Inc. - Quantisnow

Apr 01, 2025

Mar 31, 2025

Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 31, 2025

Fortress Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Mar 31, 2025

Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan

Mar 31, 2025

Mar 29, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025

Mar 28, 2025

Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges - TipRanks

Mar 28, 2025

Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan

Mar 28, 2025

MUSTANG BIO, INC. SEC 10-K Report - TradingView

Mar 28, 2025

Journey Medical Reports 2024 Financial Results - TipRanks

Mar 28, 2025

Mar 26, 2025

FDA Green Light for Journey Medical's Rosacea Drug Reshapes 2024 Performance - StockTitan

Mar 26, 2025

Mar 25, 2025